ICTA is an international leading CRO providing full-service solutions or stand-alone services for the design and conduct of Early/Late Phase clinical studies, RWE Studies, Early Access Programs (French ATUs) and off-label drug programs across a broad range of therapeutic areas in Europe and USA.
